The Science Advisory Board
We provide opportunities for news, research, and collaboration to scientists, laboratory and medical professionals, academic trainees, professors, and science advocates who are seeking to advance …
REWARDS CATALOG - scienceboard.net
Dec 4, 2023 · We provide opportunities for news, research, and collaboration to scientists, laboratory and medical professionals, academic trainees, professors, and science advocates who are seeking …
Scientists discover new pathway to treat glioblastoma
Jul 25, 2022 · Biotech company Genenta Science is developing a proprietary hematopoietic stem cell gene therapy, Temferon, for the treatment of a variety of solid tumor... A group of researchers has …
BioRestorative issued 3 patents for stem cell platform
Mar 22, 2021 · BioRestorative Therapies has been issued three separate patents related to the company's metabolic ThermoStem stem cell program.
What Is The Science Advisory Board?
The Science Advisory Board is an international community of science and medical experts. It connects a global network of research, development, and manufacturing professionals to collaborate on shaping …
New drug 'fakes out' SARS-CoV-2 to neutralize it
Dec 8, 2022 · The research team found the coronavirus can't evade the ACE2 receptor decoy because mutations in the virus that would allow it to avoid the drug, DF-COV-01, would also lower the virus's …
Object moved - scienceboard.net
Object moved Object moved to here.
BrickBio advances conjugation platform for therapeutic development
Sep 2, 2020 · BrickBio has demonstrated the power of its conjugation platform process for the commercial development of biologics in-house and with pharmaceutical partners.
CuriRx launches Advanced Bioprocessing and Analytical Center
Jan 27, 2022 · CuriRx has launched its Advanced Bioprocessing and Analytical Center to provide end-to-end support to the developers of biotherapeutics.
NanoCellect raises $35M for new development
Sep 16, 2021 · NanoCellect Biomedical has raised $35 million this year in funding rounds to accelerate the company's commercial growth plans and new product development goals.